InnerworldM to Litigation SettlementsEnglish · 4 months agoCassava Sciences Inc. agreed to pay investors about $31 million to settle claims that it misrepresented clinical study results for an Alzheimer’s disease treatmentnews.bloomberglaw.comexternal-linkmessage-square0linkfedilinkarrow-up13arrow-down10
arrow-up13arrow-down1external-linkCassava Sciences Inc. agreed to pay investors about $31 million to settle claims that it misrepresented clinical study results for an Alzheimer’s disease treatmentnews.bloomberglaw.comInnerworldM to Litigation SettlementsEnglish · 4 months agomessage-square0linkfedilink
